Trakya University Medical Faculty Hospital

Edirne 22030

2 studies enrolling now · 7 studies all time

What they study most

Advanced Breast Cancer, Atherosclerotic Cardiovascular Disease (ASCVD), Breast Neoplasms, Cancer of the Prostate, Chronic Kidney Disease (CKD), Heart Failure, Heart Failure With Preserved Ejection Fraction, Hormone Sensitive Prostate Cancer, Metastatic Breast Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC), Prostate Cancer, Refractory Metastatic Gastric Cancer

Studies at this site

• This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. — Recruiting now
• Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation — Recruiting now
• The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) — Running, not enrolling
• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling
• A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer — Running, not enrolling
• A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF) — Stopped early
• Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer — Completed